CareCloud (NASDAQ:CCLD - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.
Separately, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of CareCloud in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $3.25.
Read Our Latest Research Report on CareCloud
CareCloud Price Performance
NASDAQ:CCLD opened at $2.63 on Friday. The firm has a market capitalization of $111.75 million, a price-to-earnings ratio of 37.57 and a beta of 1.51. The business has a 50 day simple moving average of $2.30 and a 200-day simple moving average of $2.62. CareCloud has a 1 year low of $2.03 and a 1 year high of $4.01.
CareCloud (NASDAQ:CCLD - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.04. CareCloud had a return on equity of 22.31% and a net margin of 6.21%.The firm had revenue of $31.88 million for the quarter, compared to the consensus estimate of $31.85 million. CareCloud has set its FY 2026 guidance at 0.200-0.230 EPS. As a group, analysts expect that CareCloud will post 0.36 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of CCLD. HRT Financial LP bought a new position in shares of CareCloud during the fourth quarter valued at approximately $43,000. Centiva Capital LP bought a new stake in shares of CareCloud during the 3rd quarter worth approximately $47,000. Militia Capital Management LLC bought a new stake in shares of CareCloud during the 1st quarter worth approximately $54,000. American Century Companies Inc. purchased a new position in CareCloud during the 2nd quarter valued at $78,000. Finally, Man Group plc purchased a new position in CareCloud during the 4th quarter valued at $84,000. Hedge funds and other institutional investors own 10.16% of the company's stock.
About CareCloud
(
Get Free Report)
CareCloud, Inc is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.
Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CareCloud, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CareCloud wasn't on the list.
While CareCloud currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.